Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Solid Biosciences Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 39 | 36 | −3 |
| Shares | 15.8M | 16.3M | +566.4K (+3.6%) |
| Value | $74.8M | $85.6M | +$10.9M (+14.5%) |
New holders (2)
Institutions that held Solid Biosciences Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 93,103 | $487.9K | 0.01% |
| Rhumbline Advisers | 27 | $146 | 0.00% |
Sold out (5)
Institutions that held Solid Biosciences Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Pura Vida Investments, LLC | 224,902 | $1.07M |
| Tower Research Capital LLC (TRC) | 23,950 | $113.0K |
| Susquehanna International Group, LLP | 18,690 | $88.6K |
| Citadel Advisors LLC | 11,756 | $55.7K |
| Charles Schwab Investment Management Inc | 10,000 | $47.4K |